Introduction:
Chronic Kidney Disease (CKD) continues to be a major contributor to the global health burden. Hypertension is a leading cause of mortality and morbidity among CKD patients in Indonesia. Hypertension can develop into resistant hypertension (RH), thus in dialysis patients can lead to a worse outcome and might cause fatalities.
The objective of this study is to evaluate factors that contribute to resistant hypertension in patients undergoing hemodialysis.
Methods:
We performed a cross-sectional study on adult dialysis patients with resistant hypertension using a total sampling technique in Rasyida Kidney Hospital Medan, Indonesia from January to December 2023
Results:
A total of 264 individuals undergoing hemodialysis have hypertension, where 18.1 % (n=48) of patients were identified to have RH. The mean age of the patients with RH was 50.7±1.5 years, where men were 56.3% (n=27). Factors that increase the risk of RH were age over 60 years (Odds Ratio [OR] 1.8, 95% confidence interval [CI] 0,88-3.99), the duration of two years of hemodialysis (OR 0.39, 95% CI 0.20-0.77), anuria (OR 6.90, 95% CI 2.96-16.04) hypercalcemia (OR 3.00, 95% CI 0.48-18.5), and low Morisky Medication Adherence (MMA) Scale Score (OR 13.9, 95% CI 5.67–34.27).
Conclusions:
According to our study, hemodialysis patients with hypertension who are over 60 years old, the duration of two years of hemodialysis, have anuria, hypercalcemia, and low MMA Scale Score increase the risk of resistant hypertension
I have no potential conflict of interest to disclose.
I did not use generative AI and AI-assisted technologies in the writing process.